CaroMont Health is investing $200 million to expand cancer care, including a new Gastonia cancer center that will double oncology capacity to 3,000 patients per year. The center is planned to open in Fall 2028.
GSK's antibody-drug conjugate risvutatug rezetecan has received Orphan Drug Designation in Japan for small-cell lung cancer, marking its sixth global regulatory designation. The decision was based on phase I trial data showing durable responses in extensive-stage SCLC patients. The drug is currently in phase III development for relapsed ES-SCLC.
New research demonstrates that physical activity after cancer diagnosis reduces mortality risk in less common cancers and enhances circadian clock function in tumor tissue, supporting exercise as a therapeutic intervention.
Early trial of Rezatapopt shows 20% response rate in advanced cancers with p53 mutations, while researchers identify AMD3100 as potential solution to enable immunotherapy in rare liver cancer.
Study finds FDA-approved drug AMD3100 can mobilize immune T cells to attack fibrolamellar carcinoma, a rare liver cancer affecting children and young adults that has resisted immunotherapy treatment.
Researchers find that AMD3100, an existing FDA-approved drug, can reverse T-cell exclusion in fibrolamellar carcinoma, potentially allowing immunotherapy to fight the rare and fatal liver cancer that primarily affects children and young adults.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07730151 |
Efficacy and Safety of Darolutamide Combined With Docetaxel and ADT as Neoadjuvant Therapy for Locally Advanced Prostate Cancer. |
NOT_YET_RECRUITING | PHASE2 |
| NCT07678320 |
AI Technologies for Enhanced and Celerated High-Field WB-MRI |
NOT_YET_RECRUITING | |
| NCT07642063 |
Inverted-T Incision With Early Apical Release vs. Three-Lobe in Holmium Laser Enucleation of The Prostate |
ENROLLING_BY_INVITATION | NA |
| NCT07424547 |
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors |
RECRUITING | PHASE1 |
| NCT07327424 |
Feasibility of Suprapubic Transvesical Endoscopic Prostatectomy |
ACTIVE_NOT_RECRUITING | NA |
| NCT07305142 |
Comparison of the Integrated Posterior-Anterior-Lateral Approach and the Posterior Approach in Robotic Radical Prostatectomy |
COMPLETED | NA |
| NCT07296510 |
Is it Feasible to Use Data Obtained Through a Three-Dimensional Reconstructed Image to Assist in Prostate Targeted Biopsy? |
COMPLETED | |
| NCT07220720 |
POSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 Lesions |
RECRUITING | PHASE2 |
| NCT07164638 |
Lung Ultrasound Versus Inferior Vena Cava Collapsibility Index for Early Prediction of Volume Overload During Transurethral Resection of Prostate |
ENROLLING_BY_INVITATION | NA |
| NCT07020364 |
Feasibility and Safety of a Single Working Element for Bipolar and Laser Enucleation in Prostate Surgery: A Prospective Study |
RECRUITING |
